0000950170-25-010536.txt : 20250129 0000950170-25-010536.hdr.sgml : 20250129 20250129163003 ACCESSION NUMBER: 0000950170-25-010536 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250128 FILED AS OF DATE: 20250129 DATE AS OF CHANGE: 20250129 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CARLSON MARILYN R. CENTRAL INDEX KEY: 0001592848 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36075 FILM NUMBER: 25569738 MAIL ADDRESS: STREET 1: C/O EVOKE PHARMA, INC. STREET 2: 505 LOMAS SANTA FE DRIVE CITY: SOLANA BEACH STATE: CA ZIP: 92075 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Evoke Pharma Inc CENTRAL INDEX KEY: 0001403708 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 208447886 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 420 STEVENS AVENUE STREET 2: SUITE 230 CITY: SOLANA BEACH STATE: CA ZIP: 92075 BUSINESS PHONE: 858-345-1494 MAIL ADDRESS: STREET 1: 420 STEVENS AVENUE STREET 2: SUITE 230 CITY: SOLANA BEACH STATE: CA ZIP: 92075 4 1 ownership.xml 4 X0508 4 2025-01-28 0001403708 Evoke Pharma Inc EVOK 0001592848 CARLSON MARILYN R. C/O EVOKE PHARMA, INC. 420 STEVENS AVENUE, SUITE 230 SOLANA BEACH CA 92075 false true false false Chief Medical Officer false Stock Option (Right to Buy) 4.45 2025-01-28 4 A false 11000 0 A 2035-01-27 Common Stock 11000 11000 D One-thirtysixth of the total number of shares subject to the options shall vest on each monthly anniversary of January 28, 2025, subject to continuous service to the Company on each such vesting date, so that the options shall be fully vested on the third anniversary of the Vesting Commencement Date. /s/ Matthew J. D'Onofrio, Attorney-in-fact for Marilyn R. Carlson 2025-01-29